Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial)
Prevalence of atrial fibrillation (AF) increases with age, along with comorbidities and, thus, polypharmacy. Non-adherence is associated with polypharmacy. This study aimed to identify patients at risk for cardiovascular events according to their pharmacological treatment intensity and adherence. Pa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 June 2021
|
| In: |
The American journal of cardiology
Year: 2021, Jahrgang: 149, Pages: 27-35 |
| ISSN: | 1879-1913 |
| DOI: | 10.1016/j.amjcard.2021.03.024 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.amjcard.2021.03.024 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0002914921002678 
|
| Verfasserangaben: | Dominic Millenaar, Helmut Schumacher, Martina Brueckmann, John W. Eikelboom, Michael Ezekowitz, Jonathan Slawik, Sebastian Ewen, Christian Ukena, Lars Wallentin, Stuart Connolly, Salim Yusuf, and Michael Böhm |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1773574418 | ||
| 003 | DE-627 | ||
| 005 | 20230428030224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211013s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjcard.2021.03.024 |2 doi | |
| 035 | |a (DE-627)1773574418 | ||
| 035 | |a (DE-599)KXP1773574418 | ||
| 035 | |a (OCoLC)1341421952 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Millenaar, Dominic Norman |d 1989- |e VerfasserIn |0 (DE-588)1101384840 |0 (DE-627)859706028 |0 (DE-576)462773418 |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial) |c Dominic Millenaar, Helmut Schumacher, Martina Brueckmann, John W. Eikelboom, Michael Ezekowitz, Jonathan Slawik, Sebastian Ewen, Christian Ukena, Lars Wallentin, Stuart Connolly, Salim Yusuf, and Michael Böhm |
| 264 | 1 | |c 15 June 2021 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.10.2021 | ||
| 520 | |a Prevalence of atrial fibrillation (AF) increases with age, along with comorbidities and, thus, polypharmacy. Non-adherence is associated with polypharmacy. This study aimed to identify patients at risk for cardiovascular events according to their pharmacological treatment intensity and adherence. Patients (n=18,113) with a mean age of 71.5 ± 8.7 years, at high cardiovascular risk were followed between December 2005 until December 2007 for a median time of 2 years. The association between polypharmacy and adherence and their impact on cardiovascular and bleeding events were explored. Adherence was defined as a study drug intake of ≥80%. Patients with more co-medications had a higher body mass index, higher prevalence of hypertension, coronary heart disease, heart failure, and diabetes mellitus (all p < 0.0001) compared to ≤4 or 5-8 co-medications, but no differences in history of stroke (p=0.68) or transient ischemic attack (p=0.065). Across all treatments, the adjusted hazard ratios (HRs) increased in patients with more co-medications (≥9 vs ≤4) for all-cause death (HR 1.30; 1.06-1.59), major bleeding (HR 1.65; 1.33-2.05), and all bleeding events (HR 1.44; 1.31-1.59). Yearly event rates were higher in non-adherent than adherent patients for stroke and systemic embolism (SSE) (3.14 vs 1.00), all-cause death (7.76 vs 2.66), major bleeding (6.21 vs 2.65), and all bleeding (28.71 vs 19.05; all p < 0.0001). After an event the patients were more likely to become non-adherent (adherence after SSE 30.3%, after major bleeding 33.4%, after all bleeding 66.7%; all p < 0.0001). The treatment effects were consistent to the overall group in the different polypharmacy groups. In conclusion, polypharmacy and non-adherence are risk indicators for increased adverse cardiovascular and bleeding events. Dabigatran is safe to use across the full spectrum of AF patients, independent of the number of co-medications and adherence. Patients with co-medications and comorbidities require special attention and encouragement to adhere to oral anticoagulation. | ||
| 700 | 1 | |a Schumacher, Helmut |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brückmann, Martina |d 1970- |e VerfasserIn |0 (DE-588)121145069 |0 (DE-627)705257290 |0 (DE-576)292557736 |4 aut | |
| 700 | 1 | |a Eikelboom, John W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ezekowitz, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Slawik, Jonathan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ewen, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ukena, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wallentin, Lars |e VerfasserIn |4 aut | |
| 700 | 1 | |a Connolly, Stuart |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yusuf, Salim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Böhm, Michael |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of cardiology |d Amsterdam [u.a.] : Elsevier, 1958 |g 149(2021), Seite 27-35 |h Online-Ressource |w (DE-627)320596249 |w (DE-600)2019595-3 |w (DE-576)10963392X |x 1879-1913 |7 nnas |a Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial) |
| 773 | 1 | 8 | |g volume:149 |g year:2021 |g pages:27-35 |g extent:9 |a Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial) |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.amjcard.2021.03.024 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0002914921002678 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211013 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 121145069 |a Brückmann, Martina |m 121145069:Brückmann, Martina |d 60000 |e 60000PB121145069 |k 0/60000/ |p 3 | ||
| 999 | |a KXP-PPN1773574418 |e 3989295969 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"9 S."}],"language":["eng"],"id":{"doi":["10.1016/j.amjcard.2021.03.024"],"eki":["1773574418"]},"recId":"1773574418","title":[{"title_sort":"Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial)","title":"Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial)"}],"person":[{"role":"aut","given":"Dominic Norman","roleDisplay":"VerfasserIn","display":"Millenaar, Dominic Norman","family":"Millenaar"},{"display":"Schumacher, Helmut","family":"Schumacher","roleDisplay":"VerfasserIn","role":"aut","given":"Helmut"},{"role":"aut","given":"Martina","display":"Brückmann, Martina","family":"Brückmann","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Eikelboom, John W.","family":"Eikelboom","given":"John W.","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Ezekowitz, Michael","family":"Ezekowitz","given":"Michael","role":"aut"},{"role":"aut","given":"Jonathan","family":"Slawik","display":"Slawik, Jonathan","roleDisplay":"VerfasserIn"},{"display":"Ewen, Sebastian","family":"Ewen","roleDisplay":"VerfasserIn","given":"Sebastian","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Ukena, Christian","family":"Ukena","role":"aut","given":"Christian"},{"role":"aut","given":"Lars","roleDisplay":"VerfasserIn","family":"Wallentin","display":"Wallentin, Lars"},{"role":"aut","given":"Stuart","roleDisplay":"VerfasserIn","display":"Connolly, Stuart","family":"Connolly"},{"given":"Salim","role":"aut","family":"Yusuf","display":"Yusuf, Salim","roleDisplay":"VerfasserIn"},{"given":"Michael","role":"aut","family":"Böhm","display":"Böhm, Michael","roleDisplay":"VerfasserIn"}],"note":["Gesehen am 13.10.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"15 June 2021","dateIssuedKey":"2021"}],"relHost":[{"pubHistory":["1.1958 -"],"disp":"Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY trial)The American journal of cardiology","origin":[{"publisher":"Elsevier","dateIssuedDisp":"1958-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1958"}],"corporate":[{"role":"isb","display":"American College of Cardiology","roleDisplay":"Herausgebendes Organ"}],"part":{"year":"2021","volume":"149","extent":"9","pages":"27-35","text":"149(2021), Seite 27-35"},"name":{"displayForm":["ed.-in-chief Simon Dack"]},"recId":"320596249","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1879-1913"],"zdb":["2019595-3"],"eki":["320596249"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"The American journal of cardiology","subtitle":"official journal of the American College of Cardiology","title_sort":"American journal of cardiology"}],"note":["Gesehen am 22.12.10","Ungezählte Beil.: Supplement"]}],"name":{"displayForm":["Dominic Millenaar, Helmut Schumacher, Martina Brueckmann, John W. Eikelboom, Michael Ezekowitz, Jonathan Slawik, Sebastian Ewen, Christian Ukena, Lars Wallentin, Stuart Connolly, Salim Yusuf, and Michael Böhm"]}} | ||
| SRT | |a MILLENAARDCARDIOVASC1520 | ||